Montelukast Sodium
Product Images NDC 68151-4338

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68151-4338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error Of The Mean) (Image 01)

This text describes a graph showing the change in height over several weeks for three different treatments. However, specific values and data are missing or not readable. The text mentions that the standard errors of the treatment group means are too small to be visible on the plot.*

FDA Label Image

Montelukast Sodium Structural Formula (Image 02)

FDA Label Image

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N = 406; Placebo N = 270) (anova Model) (Image 03)

The text represents a chart or a graph displaying the mean percent change from baseline for weeks in treatment (0, 3, 6, 9, 12, 15) for placebo and Montelukast Sodium. No additional information relevant to what the change is related to or the context is provided.*

FDA Label Image

Label Image (Lbl681514338)

Montelukast Sodium is a chewable tablet with a strength of 4 mg manufactured by Teva. The lot number is 64M011 and expiry date is 07/14. The remaining text is not readable and appears to be a code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.